Literature DB >> 12482589

PEGylation of microspheres generates a heterogeneous population of particles with differential surface characteristics and biological performance.

J K Gbadamosi1, A C Hunter, S M Moghimi.   

Abstract

Surface PEGylation of polystyrene microspheres with methoxy-poly(ethylene glycol)-5000 (mPEG-5000) generated a heterogeneous population of entities that differed in surface characteristics and in vitro biological performance (phagocytosis and complement activation). Surface heterogeneity was determined by hydrophobic interaction chromatography, measurements of particle electrophoretic mobility in a defined field and adlayer thickness of the projected mPEG chains. The particle population separation by hydrophobic interaction chromatography demonstrated a remarkable linear relationship between the particle zeta potential and phagocytosis by J774 A1 macrophage-like cells. Microsphere populations bearing a predominant surface of mPEG molecules as high-density mushroom-brush intermediate and/or brush configuration were most resistant to phagocytosis and activated the human complement system poorly. Conversely, those populations with predominant surface mPEGs in a mushroom regime were potent activators of the complement system and were prone to phagocytosis. Therefore, surface heterogeneity explains why a fraction of intravenously injected 'long-circulating' nanoparticles is cleared rapidly by macrophages of the reticuloendothelial system. Hydrophobic interaction chromatography can readily assess the extent of surface heterogeneity of PEGylated particulate drug delivery systems and pre-select particles with optimal retention times in the blood. These observations may also be relevant with respect to successful surface camouflaging of cells, drug depots and implantable devices.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12482589     DOI: 10.1016/s0014-5793(02)03710-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  29 in total

Review 1.  Drug transport to brain with targeted nanoparticles.

Authors:  Jean-Christophe Olivier
Journal:  NeuroRx       Date:  2005-01

2.  Loading of hydrophobic materials into polymer particles: implications for fluorescent nanosensors and drug delivery.

Authors:  Huiguang Zhu; Michael J McShane
Journal:  J Am Chem Soc       Date:  2005-10-05       Impact factor: 15.419

3.  Near-Infrared-Fluorescent Erythrocyte-Mimicking Particles: Physical and Optical Characteristics.

Authors:  Jack C Tang; Allen Partono; Bahman Anvari
Journal:  IEEE Trans Biomed Eng       Date:  2018-08-20       Impact factor: 4.538

4.  Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 2. In vivo distribution and tumor localization studies.

Authors:  Dinesh Shenoy; Steven Little; Robert Langer; Mansoor Amiji
Journal:  Pharm Res       Date:  2005-11-03       Impact factor: 4.200

Review 5.  Cell-mediated drug delivery.

Authors:  Elena V Batrakova; Howard E Gendelman; Alexander V Kabanov
Journal:  Expert Opin Drug Deliv       Date:  2011-02-24       Impact factor: 6.648

6.  Complement activation turnover on surfaces of nanoparticles.

Authors:  S M Moghimi; D Simberg
Journal:  Nano Today       Date:  2017-04-12       Impact factor: 20.722

7.  Effect of the poly(ethylene glycol) (PEG) density on the access and uptake of particles by antigen-presenting cells (APCs) after subcutaneous administration.

Authors:  Xi Zhan; Kenny K Tran; Hong Shen
Journal:  Mol Pharm       Date:  2012-11-20       Impact factor: 4.939

8.  In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles.

Authors:  Rajiv Kumar; Indrajit Roy; Tymish Y Ohulchanskky; Lisa A Vathy; Earl J Bergey; Munawwar Sajjad; Paras N Prasad
Journal:  ACS Nano       Date:  2010-02-23       Impact factor: 15.881

9.  Macrophages offer a paradigm switch for CNS delivery of therapeutic proteins.

Authors:  Natalia L Klyachko; Matthew J Haney; Yuling Zhao; Devika S Manickam; Vivek Mahajan; Poornima Suresh; Shawn D Hingtgen; R Lee Mosley; Howard E Gendelman; Alexander V Kabanov; Elena V Batrakova
Journal:  Nanomedicine (Lond)       Date:  2013-11-18       Impact factor: 5.307

Review 10.  Current understanding of interactions between nanoparticles and the immune system.

Authors:  Marina A Dobrovolskaia; Michael Shurin; Anna A Shvedova
Journal:  Toxicol Appl Pharmacol       Date:  2015-12-29       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.